The overall incidence rate is 4.5 per million ( Siegel et al., 2024 ), with the incidence rate in the 0–24 age group significantly higher at 8.2 per million, showing a clear trend toward younger populations ( Nie and Peng, 2018 ; Cole et al., 2022 ).
← all excerpts
Development and pan-cancer validation of an epigenetics-based random survival forest model for prognosis prediction and drug response in OS.
1
—
—